SCHEMBL771307

SCHEMBL771307

CCCC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 5/20 0.56
GRIN3B O60391 5/20 0.56
GRIN1 Q05586 5/20 0.56
GRIN2A Q12879 5/20 0.56
GRIN2B Q13224 5/20 0.56
GRIN2C Q14957 5/20 0.56
GRIN3A Q8TCU5 5/20 0.56
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPT P10636 1/20 0.46
ATM Q13315 1/20 0.46
LMNA P02545 1/20 0.42
EPHX2 P34913 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL11633693 0.97 GRIN2D (0.54) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Hydrochloric Acid SCHEMBL11636327 0.95 GRIN2D (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL293783 0.84 GRIN2D (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5647592 0.84 GRIN2D (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL21002581 0.84 GRIN2D (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2406537 0.82 GRIN2D (0.61) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL11697939 0.82 GRIN2D (0.68) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14943583 0.82 GRIN2D (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8947159 0.80 GRIN2D (0.59) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27620610 0.80 GRIN2D (0.59) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4008251-A TRACTION FLUID ADDITIVES SUN OIL COMPANY, (SUN RESEARCH AND DEVELOPMENT CO.) 1977-02-15 US claimed
WO-2025022768-A1 CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, AND CURED PRODUCT 三菱瓦斯化学株式会社 2025-01-30 WO disclosed
WO-2025022769-A1 CYANATE ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, AND CURED PRODUCT 三菱瓦斯化学株式会社 2025-01-30 WO disclosed
EP-3713558-B1 AMINOADAMANTYL NITRATE COMPOUNDS AND THEIR USE TO TREAT CNS DISORDERS PANORAMA RES INC (US) 2024-09-11 EP disclosed
US-12071392-B2 Aminoadamantyl nitrate compounds and their use to treat CNS disorders PANORAMA RESEARCH, INC. (US) 2024-08-27 US disclosed
CN-111432810-B Aminoadamantane nitrate compounds and their use for treating CNS disorders 潘诺拉马研究公司 2024-03-08 CN disclosed
US-11681222-B2 Fluorine-containing polymer, purification method, and radiation-sensitive resin composition JSR CORPORATION (JP) 2023-06-20 US disclosed
US-20230130425-A1 AMINOADAMANTYL NITRATE COMPOUNDS AND THEIR USE TO TREAT CNS DISORDERS PANORAMA RESEARCH, INC. 2023-04-27 US disclosed
CN-110885352-B CD73 inhibitor and pharmaceutical application thereof 润佳(苏州)医药科技有限公司 2023-02-24 CN disclosed
US-11556056-B2 Salt, acid generator, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-01-17 US disclosed
EP-0105584-A1 Perfluorocarbon emulsions and their preparation and use in therapy ADAMANTECH, INC. (US) 1984-04-18 EP disclosed
WO-1984000686-A1 PERFLUOROCARBON EMULSIONS AND THEIR PREPARATION AND USE IN THERAPY SUN TECH INC (US) 1984-03-01 WO disclosed
US-4366169-A Use of perfluorocarbons as wound treatment SUN TECH, INC. (US) 1982-12-28 US disclosed
EP-0031353-A4 USE OF PERFLUOROCARBON AS BURN TREATMENT. SUNTECH (US) 1982-07-06 EP disclosed
EP-0031353-A1 USE OF PERFLUOROCARBON AS BURN TREATMENT. SUNTECH (US) 1981-07-08 EP disclosed
WO-1981000002-A1 USE OF PERFLUOROCARBON AS BURN TREATMENT SUNTECH (US) 1981-01-08 WO disclosed
US-4105798-A Perfluoro polycyclic compounds for use as synthetic blood and perfusion media SUN VENTURES, INC. (US) 1978-08-08 US disclosed
US-4043927-A Friction or tractive drive containing ethers of adamantanes SUN VENTURES, INC. (US) 1977-08-23 US disclosed
US-4041086-A HYDRAULIC FLUIDS, DIELECTRIC COOLANTS, TRACTION FLUIDS, LUBRICANTS ON SUN VENTURES, INC. (US) 1977-08-09 US disclosed
US-4008251-A TRACTION FLUID ADDITIVES SUN OIL COMPANY, (SUN RESEARCH AND DEVELOPMENT CO.) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11556056-B2 Salt, acid generator, resist composition and method for producing resist pattern CLIC1, OXSR1, RER1 GRIN2D 444/4885GRIN3B 799/4885GRIN1 89/4885
US-20230130425-A1 AMINOADAMANTYL NITRATE COMPOUNDS AND THEIR USE TO TREAT CNS DISORDERS NLN, SLC1A2, AANAT GRIN2D 462/4885GRIN3B 181/4885GRIN1 98/4885
US-12071392-B2 Aminoadamantyl nitrate compounds and their use to treat CNS disorders NLN, SLC1A2, AANAT GRIN2D 462/4885GRIN3B 181/4885GRIN1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.